MULEVACLIN
Clinical Studies on a Multivalent Vaccine for Human Visceral Leishmaniasis
| Coordinator | Etna Biotech (Italy) ; MEDITOX S.R.O ; AMVAC AG ; Autonomous University of Madrid ; Schweizerisches Tropen- und Public Health-Institut ; Infectious Disease Research Institute ; INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR-IBMC ; Istituto Superiore di Sanità ; Instituto de Salud Carlos III |
| Grant period | 2013-11-01 - 2018-10-31 |
| Funding body | European Union |
| Call number | FP7-HEALTH-2013-INNOVATION-1 |
| Grant number | 603181 |
| Identifier | G:(EU-Grant)603181 |